Significant association of insulin and proinsulin with clustering of cardiovascular risk factors

Table 2 ANCOVA analysis of TI and risk factors (age and sex are covariate).

Risk factors		N (M/F)	Median (QR)	F	P
Hypertension	Y	149/142	5.71 (3.78-7.86)	34.063	0
	N	384/521	4.60 (2.78-6.75)
Hyperglycemia	Y	17/22	7.50 (4.86-9.82)	12.116	0
	N	516/641	4.82 (2.97-7.02)
Obesity	Y	149/227	6.41 (4.39-8.46)	89.08	0
	N	382/436	4.24 (2.59-6.31)
Visceral obesity	Y	137/214	6.37 (4.54-8.31)	83.062	0
	N	395/449	4.25 (2.58-6.42)
High CH	Y	85/78	5.69 (3.66-8.19)	9.638	0.002
	N	448/585	4.76 (2.96-6.97)
High LDL	Y	72/79	5.55 (3.19-7.84)	5.301	0.021
	N	460/579	4.79 (2.97-7.00)
High TG	Y	66/74	6.94 (4.89-8.62)	39.522	0
	N	467/589	4.64 (2.82-6.76)
Low HDL	Y	258/297	5.31 (3.19-7.57)	8.829	0.003
	N	275/366	4.63 (2.82-6.69)
Risk factor score	0	134/180	3.81 (2.54-5.84)	21.136	0
	1	170/220	4.59 (2.79-6.63)
	2	123/151	5.19 (3.19-7.16)
	3	56/65	6.15 (4.23-7.92)
	4	29/27	7.75 (5.53-9.45)
	≥5	18/15	7.81 (5.74-10.20)

M/F, male/female; Y or N, presence or absence of risk factors.